Your browser doesn't support javascript.
Distress in a Pandemic: Association of the Coronavirus Disease-2019 Pandemic with Distress and Quality of Life in Hematopoietic Stem Cell Transplantation.
Amonoo, Hermioni L; Topping, Carlisle E W; Clay, Madison A; Reynolds, Matthew J; Rice, Julia; Harnedy, Lauren E; Longley, Regina M; LeBlanc, Thomas W; Greer, Joseph A; Chen, Yi-Bin; DeFilipp, Zachariah; Lee, Stephanie J; Temel, Jennifer S; El-Jawahri, Areej.
  • Amonoo HL; Department of Psychiatry, Brigham and Women's Hospital, Boston, Massachusetts; Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts. Electronic address: hermioni_amonoo@dfci.harvard.edu.
  • Topping CEW; Department of Medicine, Division of Hematology and Oncology, Massachusetts General Hospital, Boston, Massachusetts.
  • Clay MA; Department of Medicine, Division of Hematology and Oncology, Massachusetts General Hospital, Boston, Massachusetts.
  • Reynolds MJ; Department of Medicine, Division of Hematology and Oncology, Massachusetts General Hospital, Boston, Massachusetts.
  • Rice J; Department of Medicine, Division of Hematology and Oncology, Massachusetts General Hospital, Boston, Massachusetts.
  • Harnedy LE; Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts.
  • Longley RM; Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts.
  • LeBlanc TW; Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, North Carolina.
  • Greer JA; Harvard Medical School, Boston, Massachusetts; Department of Medicine, Division of Hematology and Oncology, Massachusetts General Hospital, Boston, Massachusetts; Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts.
  • Chen YB; Harvard Medical School, Boston, Massachusetts; Department of Medicine, Division of Hematology and Oncology, Massachusetts General Hospital, Boston, Massachusetts.
  • DeFilipp Z; Harvard Medical School, Boston, Massachusetts; Department of Medicine, Division of Hematology and Oncology, Massachusetts General Hospital, Boston, Massachusetts.
  • Lee SJ; Division of Clinical Research, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, Washington.
  • Temel JS; Harvard Medical School, Boston, Massachusetts; Department of Medicine, Division of Hematology and Oncology, Massachusetts General Hospital, Boston, Massachusetts.
  • El-Jawahri A; Harvard Medical School, Boston, Massachusetts; Department of Medicine, Division of Hematology and Oncology, Massachusetts General Hospital, Boston, Massachusetts.
Transplant Cell Ther ; 27(12): 1015.e1-1015.e7, 2021 12.
Article in English | MEDLINE | ID: covidwho-1482761
ABSTRACT
The global coronavirus disease 2019 (COVID-19) pandemic has drastically disrupted cancer care, potentially exacerbating patients' distress levels. Patients undergoing hematopoietic stem cell transplantation (HSCT) may be especially vulnerable to this pandemic stress. However, the associations of the COVID-19 pandemic with distress, fatigue, and quality of life (QoL) are not well understood in this population. In a cross-sectional analysis of data from 205 patients undergoing HSCT enrolled in a supportive care trial, we compared baseline pre-HSCT distress symptoms (depression, anxiety, and posttraumatic stress disorder [PTSD]), fatigue, and QoL between enrollees before (ie, March 2019-January 2020) and during (ie, March 2020-January 2021) the COVID-19 pandemic. We used linear regression models adjusting for sociodemographics and cancer diagnosis to examine the associations between enrollment period and patient-reported outcomes. We used semistructured qualitative interviews in 20 allogeneic HSCT recipients who were ≥3-months post-HSCT to understand the impact of the COVID-19 pandemic on their recovery post-HSCT. One hundred twenty-four participants enrolled before COVID-19, and 81 participants enrolled during the pandemic. The 2 cohorts had similar baseline demographics and disease risk factors. In multivariate regression models, enrollment during COVID-19 was not associated with pre-HSCT symptoms of depression, anxiety, PTSD, fatigue, or QoL impairment. COVID-19-era participants reported themes of negative (eg, increased isolation) and positive (eg, engagement with meaningful activities) implications of the pandemic on HSCT recovery. We found no differences in pre-HSCT distress, fatigue, or QoL in patients undergoing HSCT before or during the COVID-19 pandemic; however, patients in early recovery post-HSCT report both negative and positive implications of the COVID-19 pandemic in their lives.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Hematopoietic Stem Cell Transplantation / COVID-19 Type of study: Cohort study / Observational study / Prognostic study / Qualitative research / Randomized controlled trials Limits: Humans Language: English Journal: Transplant Cell Ther Year: 2021 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Hematopoietic Stem Cell Transplantation / COVID-19 Type of study: Cohort study / Observational study / Prognostic study / Qualitative research / Randomized controlled trials Limits: Humans Language: English Journal: Transplant Cell Ther Year: 2021 Document Type: Article